ABCB6 and neoplasm: The pretreatment of our three cell lines grown in a monolayer with I-CBP112 for 72 h was sufficient to substantially reduce the ABC protein levels in the cell membranes, but the variability in the exposure of the tumor cells to the drugs may alter their expected responses to I-CBP112.